A benchmark study of loop modeling methods applied to G protein-coupled receptors
暂无分享,去创建一个
Judith A Cole | Lee H Wink | Daniel L Baker | Abby L Parrill | Lee H. Wink | D. Baker | A. Parrill | J. Cole
[1] Oliver P. Ernst,et al. Crystal structure of metarhodopsin II , 2011, Nature.
[2] Hualiang Jiang,et al. Structure of the full-length glucagon class B G protein-coupled receptor , 2017, Nature.
[3] K. Garcia,et al. Adrenaline-activated structure of the β2-adrenoceptor stabilized by an engineered nanobody , 2013, Nature.
[4] J. Wess,et al. Activation and allosteric modulation of a muscarinic acetylcholine receptor , 2013, Nature.
[5] Gebhard F. X. Schertler,et al. The 2.1 Å Resolution Structure of Cyanopindolol-Bound β1-Adrenoceptor Identifies an Intramembrane Na+ Ion that Stabilises the Ligand-Free Receptor , 2014, PloS one.
[6] R. Stenkamp. Alternative models for two crystal structures of bovine rhodopsin , 2008, Acta crystallographica. Section D, Biological crystallography.
[7] David Baker,et al. High-Resolution Modeling of Transmembrane Helical Protein Structures from Distant Homologues , 2014, PLoS Comput. Biol..
[8] Hualiang Jiang,et al. Agonist-bound structure of the human P2Y12 receptor , 2014, Nature.
[9] J. Pantel,et al. Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. , 2006, The Journal of clinical investigation.
[10] Matthew J. O’Meara,et al. Combined covalent-electrostatic model of hydrogen bonding improves structure prediction with Rosetta. , 2015, Journal of chemical theory and computation.
[11] Gebhard F. X. Schertler,et al. Two distinct conformations of helix 6 observed in antagonist-bound structures of a β1-adrenergic receptor , 2011, Proceedings of the National Academy of Sciences.
[12] Charles L. Brooks,et al. Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008 , 2009, Nature Reviews Drug Discovery.
[13] Yoshinori Shichida,et al. Functional role of internal water molecules in rhodopsin revealed by x-ray crystallography , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[14] T. Gudermann,et al. Receptors and G proteins as primary components of transmembrane signal transduction , 1995, Journal of Molecular Medicine.
[15] E. Coutsias,et al. Sub-angstrom accuracy in protein loop reconstruction by robotics-inspired conformational sampling , 2009, Nature Methods.
[16] Christopher G. Tate,et al. Crystal Structures of a Stabilized β1-Adrenoceptor Bound to the Biased Agonists Bucindolol and Carvedilol , 2012, Structure.
[17] S. Rasmussen,et al. The structure and function of G-protein-coupled receptors , 2009, Nature.
[18] Chris de Graaf,et al. Structure of the human glucagon class B G-protein-coupled receptor , 2013, Nature.
[19] K. Diederichs,et al. In meso in situ serial X-ray crystallography of soluble and membrane proteins at cryogenic temperatures , 2016, Acta crystallographica. Section D, Structural biology.
[20] Christopher I. Bayly,et al. Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: II. Parameterization and validation , 2002, J. Comput. Chem..
[21] Christopher G. Tate,et al. Biophysical Fragment Screening of the β1-Adrenergic Receptor: Identification of High Affinity Arylpiperazine Leads Using Structure-Based Drug Design , 2013, Journal of medicinal chemistry.
[22] T. Nanevicz,et al. Thrombin Receptor Activating Mutations , 1996, The Journal of Biological Chemistry.
[23] Vadim Cherezov,et al. A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. , 2008, Structure.
[24] Cheng Zhang,et al. Structure and Function of an Irreversible Agonist-β2 Adrenoceptor complex , 2010, Nature.
[25] M. Congreve,et al. Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine. , 2011, Structure.
[26] R. Abagyan,et al. Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV , 2017, Immunity.
[27] Hualiang Jiang,et al. Two disparate ligand-binding sites in the human P2Y1 receptor , 2015, Nature.
[28] Jonathan S. Mason,et al. Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design , 2012, Journal of medicinal chemistry.
[29] Brian K. Kobilka,et al. N-Terminal T4 Lysozyme Fusion Facilitates Crystallization of a G Protein Coupled Receptor , 2012, PloS one.
[30] Roland L. Dunbrack,et al. The Rosetta all-atom energy function for macromolecular modeling and design , 2017, bioRxiv.
[31] Chris de Graaf,et al. Generic GPCR residue numbers - aligning topology maps while minding the gaps. , 2015, Trends in pharmacological sciences.
[32] Ruben Abagyan,et al. Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment. , 2011, Structure.
[33] Jonathan A. Javitch,et al. Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist , 2010, Science.
[34] David Baker,et al. Protein-protein docking with backbone flexibility. , 2007, Journal of molecular biology.
[35] X. Deupí,et al. Structural role of the T94I rhodopsin mutation in congenital stationary night blindness , 2016, EMBO reports.
[36] Alexander S. Rose,et al. Crystal structure of a common GPCR-binding interface for G protein and arrestin , 2014, Nature Communications.
[37] M. Sansom,et al. Structural basis for Smoothened regulation by its extracellular domains , 2016, Nature.
[38] Jillian Baker,et al. Pharmacological Analysis and Structure Determination of 7-Methylcyanopindolol–Bound β1-Adrenergic Receptor , 2015, Molecular Pharmacology.
[39] Amelie Stein,et al. Improvements to Robotics-Inspired Conformational Sampling in Rosetta , 2013, PloS one.
[40] Krzysztof Palczewski,et al. Crystal structure of a photoactivated deprotonated intermediate of rhodopsin , 2006, Proceedings of the National Academy of Sciences.
[41] Arthur Christopoulos,et al. Prediction of Loops in G Protein-Coupled Receptor Homology Models: Effect of Imprecise Surroundings and Constraints , 2016, J. Chem. Inf. Model..
[42] Jie Yin,et al. High-resolution crystal structure of the human CB1 cannabinoid receptor , 2016, Nature.
[43] Anton Barty,et al. Lipidic cubic phase injector facilitates membrane protein serial femtosecond crystallography , 2014, Nature Communications.
[44] T. Ceska,et al. Crystal structure of the adenosine A2A receptor bound to an antagonist reveals a potential allosteric pocket , 2017, Proceedings of the National Academy of Sciences.
[45] Roland L. Dunbrack,et al. Nonplanar peptide bonds in proteins are common and conserved but not biased toward active sites , 2011, Proceedings of the National Academy of Sciences.
[46] Jianyun Huang,et al. Crystal Structure of Oligomeric β1-Adrenergic G Protein- Coupled Receptors in Ligand-Free Basal State , 2013, Nature Structural &Molecular Biology.
[47] Marcus Elstner,et al. The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. , 2004, Journal of molecular biology.
[48] S. P. Andrews,et al. Extra-helical binding site of a glucagon receptor antagonist , 2016, Nature.
[49] David E. Kim,et al. Simultaneous Optimization of Biomolecular Energy Functions on Features from Small Molecules and Macromolecules. , 2016, Journal of chemical theory and computation.
[50] R. Abagyan,et al. Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.
[51] A. IJzerman,et al. Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength. , 2016, Journal of medicinal chemistry.
[52] B. Krumm,et al. Structural prerequisites for G-protein activation by the neurotensin receptor , 2015, Nature Communications.
[53] Vadim Cherezov,et al. Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs , 2014, Nature Communications.
[54] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2000, Science.
[55] Liaoyuan A. Hu,et al. Structural Basis for Apelin Control of the Human Apelin Receptor. , 2017, Structure.
[56] S. Rasmussen,et al. Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.
[57] Xavier Deupi,et al. Stabilized G protein binding site in the structure of constitutively active metarhodopsin-II , 2011, Proceedings of the National Academy of Sciences.
[58] S. Iwata,et al. G protein-coupled receptor inactivation by an allosteric inverse-agonist antibody , 2011, Nature.
[59] Albert C. Pan,et al. Structure and Dynamics of the M3 Muscarinic Acetylcholine Receptor , 2012, Nature.
[60] Anton Barty,et al. Structural basis for bifunctional peptide recognition at human δ-Opioid receptor , 2015, Nature Structural &Molecular Biology.
[61] D C Teller,et al. Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). , 2001, Biochemistry.
[62] C. Makino,et al. Binding of more than one retinoid to visual opsins. , 2010, Biophysical journal.
[63] A. Sali,et al. Protein Structure Prediction and Structural Genomics , 2001, Science.
[64] S. Rasmussen,et al. Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.
[65] Chris de Graaf,et al. Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators , 2017, Nature.
[66] Gert Vriend,et al. Alpha-Bulges in G Protein-Coupled Receptors , 2014, International journal of molecular sciences.
[67] D. Veprintsev,et al. Insights into congenital stationary night blindness based on the structure of G90D rhodopsin , 2013, EMBO reports.
[68] Arthur Christopoulos,et al. Crystal structures of the M1 and M4 muscarinic acetylcholine receptors , 2016, Nature.
[69] N. Vaidehi,et al. Structure and dynamics of a constitutively active neurotensin receptor , 2016, Scientific Reports.
[70] Arthur Christopoulos,et al. Structure of the Adenosine A1 Receptor Reveals the Basis for Subtype Selectivity , 2017, Cell.
[71] R. Abagyan,et al. Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography. , 2010, Journal of the American Chemical Society.
[72] Andreas Plückthun,et al. Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli , 2014, Proceedings of the National Academy of Sciences.
[73] John P. Overington,et al. How many drug targets are there? , 2006, Nature Reviews Drug Discovery.
[74] R. Stevens,et al. Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions , 2012, Science.
[75] Patrik Johansson,et al. Structural insight into allosteric modulation of protease-activated receptor 2 , 2017, Nature.
[76] Christopher G. Tate,et al. Structure of the adenosine A(2A) receptor bound to an engineered G protein (vol 536, pg 104, 2016) , 2016 .
[77] Steven M. Moss,et al. Structure of the human P2Y12 receptor in complex with an antithrombotic drug , 2014, Nature.
[78] R. Read,et al. Decoding Corticotropin-Releasing Factor Receptor Type 1 Crystal Structures , 2017, Current molecular pharmacology.
[79] A. Leslie,et al. Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation , 2011, Nature.
[80] Adrian A Canutescu,et al. Cyclic coordinate descent: A robotics algorithm for protein loop closure , 2003, Protein science : a publication of the Protein Society.
[81] R. Stevens,et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. , 2007, Science.
[82] M. Burghammer,et al. Crystal structure of the human β2 adrenergic G-protein-coupled receptor , 2007, Nature.
[83] M. Rudd,et al. Structural Basis for Selectivity and Diversity in Angiotensin II Receptors , 2017, Nature.
[84] Aashish Manglik,et al. Allosteric Nanobodies Reveal the Dynamic Range and Diverse Mechanisms of GPCR Activation , 2016, Nature.
[85] Sebastian Kmiecik,et al. Structure Prediction of the Second Extracellular Loop in G-Protein-Coupled Receptors , 2014, Biophysical journal.
[86] Shan Jiang,et al. Crystal structures of agonist-bound human cannabinoid receptor CB1 , 2017, Nature.
[87] R. Stevens,et al. Crystal Structure of the Human Cannabinoid Receptor CB1 , 2016, Cell.
[88] Sujata Sharma,et al. Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40 , 2017, Nature Structural &Molecular Biology.
[89] Patrick Scheerer,et al. Crystal structure of the ligand-free G-protein-coupled receptor opsin , 2008, Nature.
[90] Gebhard F. X. Schertler,et al. Structure of a β1-adrenergic G-protein-coupled receptor , 2008, Nature.
[91] Ron O. Dror,et al. High-resolution crystal structure of human Protease-Activated Receptor 1 bound to the antagonist vorapaxar , 2012, Nature.
[92] Christopher G. Tate,et al. The structural basis for agonist and partial agonist action on a β1-adrenergic receptor , 2010, Nature.
[93] B. Honig,et al. A hierarchical approach to all‐atom protein loop prediction , 2004, Proteins.
[94] K. Nechvíle. The High Resolution , 2005 .
[95] R. Stevens,et al. The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.
[96] Tsutomu Kouyama,et al. Crystal structure of squid rhodopsin , 2008, Nature.
[97] C. Zhang,et al. Covalent agonists for studying G protein-coupled receptor activation , 2014, Proceedings of the National Academy of Sciences.
[98] Manfred Burghammer,et al. Structure of bovine rhodopsin in a trigonal crystal form. , 2003, Journal of molecular biology.
[99] Tetsuji Okada,et al. Photoisomerization mechanism of rhodopsin and 9-cis-rhodopsin revealed by x-ray crystallography. , 2007, Biophysical journal.
[100] E. Pai,et al. Opsin, a structural model for olfactory receptors? , 2013, Angewandte Chemie.
[101] R. Stevens,et al. Structure of an Agonist-Bound Human A2A Adenosine Receptor , 2011, Science.
[102] J. Simms,et al. Lifting the lid on GPCRs: the role of extracellular loops , 2011, British journal of pharmacology.
[103] T. Okada,et al. Local peptide movement in the photoreaction intermediate of rhodopsin , 2006, Proceedings of the National Academy of Sciences.
[104] A. Vahedi-Faridi,et al. The High-Resolution Structure of Activated Opsin Reveals a Conserved Solvent Network in the Transmembrane Region Essential for Activation. , 2015, Structure.
[105] Manfred Burghammer,et al. Crystal structure of a thermally stable rhodopsin mutant. , 2007, Journal of molecular biology.
[106] Anton Barty,et al. Native phasing of x-ray free-electron laser data for a G protein–coupled receptor , 2016, Science Advances.
[107] W. Baumeister,et al. Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor–Gs complex , 2018, Nature.
[108] J. Shiloach,et al. Structure of the agonist-bound neurotensin receptor , 2012, Nature.
[109] Helgi B. Schiöth,et al. Structural diversity of G protein-coupled receptors and significance for drug discovery , 2008, Nature Reviews Drug Discovery.
[110] J. Klco,et al. Essential role for the second extracellular loop in C5a receptor activation , 2005, Nature Structural &Molecular Biology.
[111] J. Renger,et al. Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors , 2016, Nature Structural &Molecular Biology.
[112] Paul R. Gerber,et al. MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry , 1995, J. Comput. Aided Mol. Des..
[113] Bryan L. Roth,et al. Molecular control of δ-opioid receptor signalling , 2014, Nature.
[114] Yasuyuki Kihara,et al. Crystal Structure of Antagonist Bound Human Lysophosphatidic Acid Receptor 1 , 2015, Cell.
[115] O. Nureki,et al. X-ray structures of endothelin ETB receptor bound to clinical antagonist bosentan and its analog , 2017, Nature Structural &Molecular Biology.
[116] A. J. Venkatakrishnan,et al. Structural basis for chemokine recognition and activation of a viral G protein–coupled receptor , 2014, Science.
[117] Jack Snoeyink,et al. Scientific benchmarks for guiding macromolecular energy function improvement. , 2013, Methods in enzymology.
[118] Jens Meiler,et al. Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator , 2014, Science.
[119] Hugh Rosen,et al. Crystal Structure of a Lipid G Protein–Coupled Receptor , 2012, Science.
[120] W. Weis,et al. Modified T4 Lysozyme Fusion Proteins Facilitate G Protein-Coupled Receptor Crystallogenesis. , 2014, Structure.
[121] Wouter Boomsma,et al. Full cyclic coordinate descent: solving the protein loop closure problem in Cα space , 2005, BMC Bioinformatics.
[122] David Baker,et al. Protein structure prediction and analysis using the Robetta server , 2004, Nucleic Acids Res..
[123] Bryan L. Roth,et al. Structure of the human smoothened receptor bound to an antitumour agent , 2013, Nature.
[124] C. Murga,et al. The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. , 2007, Biochimica et biophysica acta.
[125] R. Stevens,et al. The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor. , 2015, Structure.
[126] Oliver P. Ernst,et al. Crystal structure of opsin in its G-protein-interacting conformation , 2008, Nature.
[127] Arthur Christopoulos,et al. Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor Ligands* , 2007, Journal of Biological Chemistry.
[128] L. Pardo,et al. Ligand-specific regulation of the extracellular surface of a G protein coupled receptor , 2009, Nature.
[129] A. Kruse,et al. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist , 2011, Nature.
[130] Ruben Abagyan,et al. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine , 2015, Science.
[131] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[132] The cubicon method for concentrating membrane proteins in the cubic mesophase , 2017, Nature Protocols.
[133] Wen-Hsin Lee,et al. Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody , 2013 .
[134] Bryan L. Roth,et al. Structure of the Nociceptin/Orphanin FQ Receptor in Complex with a Peptide Mimetic , 2012, Nature.
[135] Ali Jazayeri,et al. Crystal structure of the GLP-1 receptor bound to a peptide agonist , 2017, Nature.
[136] A. Leslie,et al. Molecular Determinants of CGS21680 Binding to the Human Adenosine A2A Receptor , 2015, Molecular Pharmacology.
[137] T. Okada,et al. Crystallographic analysis of primary visual photochemistry. , 2006, Angewandte Chemie.
[138] P. Stewart,et al. Photocyclic behavior of rhodopsin induced by an atypical isomerization mechanism , 2017, Proceedings of the National Academy of Sciences.
[139] Alexander S. Hauser,et al. GPCRdb in 2018: adding GPCR structure models and ligands , 2017, Nucleic Acids Res..
[140] Tomohiro Nishizawa,et al. Activation mechanism of endothelin ETB receptor by endothelin-1 , 2016, Nature.
[141] Jeffrey Skolnick,et al. Fast procedure for reconstruction of full‐atom protein models from reduced representations , 2008, J. Comput. Chem..
[142] G. V. van Westen,et al. Importance of the extracellular loops in G protein-coupled receptors for ligand recognition and receptor activation. , 2011, Trends in pharmacological sciences.
[143] Gebhard F. X. Schertler,et al. The structural basis of agonist-induced activation in constitutively active rhodopsin , 2011, Nature.
[144] Ruben Abagyan,et al. Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: meeting new challenges. , 2014, Structure.